<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Health / Drug Price Competition and Patent Term Restoration Act / Generic drug / Abbreviated New Drug Application / Food and Drug Administration / New Drug Application / Waxman / Patent / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy
Date: 2003-02-14 09:28:57
Pharmaceutical industry
Health
Drug Price Competition and Patent Term Restoration Act
Generic drug
Abbreviated New Drug Application
Food and Drug Administration
New Drug Application
Waxman
Patent
Pharmaceutical sciences
Pharmacology
Pharmaceuticals policy

a Barr Laboratories, 0 Inc.

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 163,55 KB

Share Document on Facebook

Similar Documents

Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

DocID: 1ptht - View Document

PUBLIC LAW 105–115—NOV. 21, 1997  FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997  111 STAT. 2296

PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296

DocID: 1pnIy - View Document

Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry

Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry

DocID: 1p93k - View Document

Case 2:06-cvHAA-ES Document 71  FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT

Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT

DocID: 1m2hg - View Document

Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc

Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc

DocID: 1lmCl - View Document